Atomistic insight into the essential binding event of ACE2-derived peptides to the SARS-CoV-2 spike protein

SARTO, CAROLINA; FLOREZ-RUEDA, SEBASTIÁN; ARRAR, MEHRNOOSH; HACKENBERGER, CHRISTIAN P.R.; LAUSTER, DANIEL; DI LELLA, SANTIAGO

BIOLOGICAL CHEMISTRY

WALTER DE GRUYTER & CO

Lugar: Berlin; Año: 2022 vol. 0

1431-6730

The pathogenic agent of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters into human cells through the interaction between the receptor binding domain (RBD) of its spike glycoprotein and the angiotensin-converting enzyme 2 (ACE2) receptor. Efforts have been made towards finding antivirals that block this interaction, therefore preventing infection. Here, we determined the binding affinity of ACE2-derived peptides to the RBD of SARS-CoV-2 experimentally and performed MD simulations in order to understand key characteristics of their interaction. One of the peptides, p6, binds to the RBD of SARS-CoV-2 with nM affinity. Although the ACE2-derived peptides retain conformational flexibility when bound to SARS-CoV-2 RBD, we identified residues T27 and K353 as critical anchors mediating the interaction. New ACE2-derived peptides were developed based on the p6-RBD interface analysis and expecting the native conformation ofthe ACE2 to be maintained. Furthermore, we found a correlation between the helicity in trifluoroethanol and the binding affinity to RBD of the new peptides. Under the hypothesis that the conservation of peptide secondary structure is decisive to the binding affinity, we developed acyclized version of p6 which had more helicity than p6 and approximately half of its K D value.